NEW YORK (GenomeWeb News) – Life Technologies today announced its participation in the Stratified Medicine Scotland Innovation Centre, or SMS-IC, a collaboration among academic, industrial, and the UK's National Health Service community to create a stratified medicine research infrastructure.

Life Tech is the lead commercial partner in SMS-IC along with biomedical informatics firm Aridhia, and the Ion Proton benchtop sequencer will be used as the primary tool "to drive discovery and genetic analysis."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.